Please login to the form below

Not currently logged in
Email:
Password:

Novartis’ Dr Esteban Pombo-Villar joins Oxford BioTherapeutics

Will head the UK biotech's new development operations in Switzerland

Dr Esteban Pombo Villar - Oxford BioTherapeuticsDr Esteban Pombo-Villar has left Novartis after 24 years to become chief operations officer of Oxford BioTherapeutics (OBT).

Dr Pombo-Villar will oversee the UK-based biotech's newly-created clinical development operations in Basel, Switzerland, as the company takes its therapeutic antibody and antibody drug conjugate (ADC) oncology programmes into clinical development.

During his time at Novartis Dr Pombo-Villar had several roles, the most recent of which was head of alliance management at the Novartis Institute for Biomedical Research (NIBR), where he focused creating and managing the company's collaborative efforts.

He initially joined Sandoz Neuroscience Research in 1988 to work on drug discovery projects and to investigate the potential of emerging technologies and remained at the company following Sandoz' merger with Ciba-Geigy in 1996 to form Novartis.

Dr Christian Rohlff, CEO of OBT, said: “I am very pleased to welcome Esteban to OBT and to officially open our new clinical operations site in Basel, Switzerland. Esteban's extensive executive leadership experience in the industry will bring considerable value to OBT as we advance our highly promising lead programmes into the clinic.”

4th May 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
ENGAGE

ENGAGE is a unique new patient engagement consultancy that brings together the wealth of patient expertise present in the OPEN...

Latest intelligence

Russian innovation at the crossroads
Despite improvements, investors face rising risks...
blog-icon_webinar_wow_c.png
E-detailing content wow factor in 2015
Many companies are reporting that the iPad novelty has worn off and healthcare professionals are demanding more than just another animation presented on a mobile device. So what exactly are...
Free White Paper: Multichannel Marketing for Pharma
Transitioning successfully to multichannel marketing takes careful planning. When done right, pharma can deliver a personalised experience for each customer. Download our white paper to learn how...